Research  

Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma

Antoni Ribas, John M Kirkwood, Michael B Atkins, Theresa L Whiteside, William Gooding, Andreas Kovar, Stephen D Gillies, Oscar Kashala, Michael A Morse Journal of Translational Medicine 2009, 7:68 (29 July 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research  

Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failure

David E Lanfear, Reema Hasan, Ramesh C Gupta, Celeste Williams, Barbara Czerska, Cristina Tita, Rasha Bazari, Hani N Sabbah Journal of Translational Medicine 2009, 7:67 (29 July 2009)

Abstract | Full text | PDF | PubMed

Research  

Vasoprotective effects of human CD34+ cells: towards clinical applications

Thomas J Kiernan, Barry A Boilson, Tyra A Witt, Allan B Dietz, Amir Lerman, Robert D Simari Journal of Translational Medicine 2009, 7:66 (29 July 2009)

Abstract | Full text | PDF | PubMed

Methodology  

Development of a microarray platform for FFPET profiling: application to the classification of human tumors

Sven Duenwald, Mingjie Zhou, Yanqun Wang, Serguei Lejnine, Amit Kulkarni, Jaime Graves, Ryan Smith, John Castle, George Tokiwa, Bernard Fine, Hongyue Dai, Thomas Fare, Matthew Marton Journal of Translational Medicine 2009, 7:65 (28 July 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research  

Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients – a pilot study

Sara Bremer, Nils T Vethe, Helge Rootwelt, Pål F Jørgensen, Jean Stenstrøm, Hallvard Holdaas, Karsten Midtvedt, Stein Bergan Journal of Translational Medicine 2009, 7:64 (27 July 2009)

Abstract | Full text | PDF | PubMed

Research  

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells

Ki Kim, Yanhua Xie, Ewan M Tytler, Richard Woessner, Gil Mor, Ayesha B Alvero Journal of Translational Medicine 2009, 7:63 (20 July 2009)

Abstract | Full text | PDF | PubMed

Research  

Hypoglycemic and beta cell protective effects of andrographolide analogue for diabetes treatment

Zaijun Zhang, Jie Jiang, Pei Yu, Xiangping Zeng, James W Larrick, Yuqiang Wang Journal of Translational Medicine 2009, 7:62 (16 July 2009)

Abstract | Full text | PDF | PubMed

Research  

Sperm protein 17 is expressed in the sperm fibrous sheath

Maurizio Chiriva-Internati, Nicoletta Gagliano, Elena Donetti, Francesco Costa, Fabio Grizzi, Barbara Franceschini, Elena Albani, Paolo E Levi-Setti, Magda Gioia, Marjorie Jenkins, Everardo Cobos, W Martin Kast Journal of Translational Medicine 2009, 7:61 (15 July 2009)

Abstract | Full text | PDF | PubMed

Research  

Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer

Monika Pietrowska, Lukasz Marczak, Joanna Polanska, Katarzyna Behrendt, Elzbieta Nowicka, Anna Walaszczyk, Aleksandra Chmura, Regina Deja, Maciej Stobiecki, Andrzej Polanski, Rafal Tarnawski, Piotr Widlak Journal of Translational Medicine 2009, 7:60 (13 July 2009)

Abstract | Full text | PDF | PubMed

Research  

A novel role of HLA class I in the pathology of medulloblastoma

Courtney Smith, Mariarita Santi, Bhargavi Rajan, Elisabeth J Rushing, Mi Choi, Brian R Rood, Robert Cornelison, Tobey J MacDonald, Stanislav Vukmanovic Journal of Translational Medicine 2009, 7:59 (12 July 2009)

Abstract | Full text | PDF | PubMed

Research  

Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations

Ramon Kaneno, Galina V Shurin, Irina L Tourkova, Michael R Shurin Journal of Translational Medicine 2009, 7:58 (10 July 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Editorial  

The "Excellence in Translational Medicine" and "Bedside-to-Bench" Awards 2007–08

Richard J Ablin, Francesco M Marincola, Pier Natali Journal of Translational Medicine 2009, 7:57 (9 July 2009)

Full text | PDF | PubMed

Research  

Higher percentage of CD133⁺ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB

Chun-Yan Li, Bao-Xiu Li, Yi Liang, Rui-Qing Peng, Ya Ding, Da-Zhi Xu, Xin Zhang, Zhi-Zhong Pan, De-Sen Wan, Yi-Xin Zeng, Xiao-Feng Zhu, Xiao-Shi Zhang Journal of Translational Medicine 2009, 7:56 (7 July 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Methodology  

The chemiluminescence based Ziplex^® automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip^® expression profiles

Michael CJ Quinn, Daniel J Wilson, Fiona Young, Adam A Dempsey, Suzanna L Arcand, Ashley H Birch, Paulina M Wojnarowicz, Diane Provencher, Anne-Marie Mes-Masson, David Englert, Patricia N Tonin Journal of Translational Medicine 2009, 7:55 (6 July 2009)

Abstract | Full text | PDF | PubMed